Edition:
India

Aurobindo Pharma Ltd (ARBN.NS)

ARBN.NS on National Stock Exchange of India

768.30INR
22 Mar 2019
Change (% chg)

Rs-8.30 (-1.07%)
Prev Close
Rs776.60
Open
Rs779.00
Day's High
Rs786.90
Day's Low
Rs762.15
Volume
1,680,669
Avg. Vol
2,527,879
52-wk High
Rs830.45
52-wk Low
Rs527.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Dec 52,696.70 12.150
Sep 47,514.00 10.440
Jun 42,502.70 7.780
FY 2018 Mar '18 40,490.90 9.020
Dec 43,361.10 10.160
Sep 44,358.90 13.333
Jun 36,787.50 8.850
FY 2017 Mar '17 36,416.30 9.096
Dec 39,061.80 9.888
Sep 37,754.50 10.400
Jun 37,665.90 9.996
 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 3 49,254.00 51,876.90 46,897.00 45,270.00
Year Ending Mar-19 32 190,763.00 203,722.00 175,850.00 184,035.00
Year Ending Mar-20 12 270,127.00 296,111.00 245,518.00 201,437.00
Earnings (per share)
Quarter Ending Mar-19 2 10.83 11.09 10.57 10.33
Year Ending Mar-19 33 43.18 54.40 37.00 47.83
Year Ending Mar-20 15 55.66 65.70 50.60 53.08
LT Growth Rate (%) 2 13.18 15.70 10.66 10.57
Sales and Profit Figures in India Rupee (INR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 19.51 29.30 32.54
P/E High - Last 5 Yrs. 22.63 43.23 48.15
P/E Low - Last 5 Yrs. 12.72 22.71 23.42
Beta 0.84 0.86 0.87
Price to Sales (TTM) 2.91 6.59 8.39
Price to Book (MRQ) -- 5.12 5.27
Price to Tangible Book (MRQ) -- 5.84 6.74
Price to Cash Flow (TTM) 16.26 23.07 24.12
% Owned Institutions -- 0.87 1.65

Dividends

  Company industry sector
Dividend Yield 0.52 1.43 1.35
Dividend Yield - 5 Year Avg 0.40 1.45 1.37
Dividend 5 Year Growth Rate 37.97 3.99 4.70
Payout Ratio(TTM) 0.00 42.18 39.60

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -2.33 5.43 13.45
Sales (TTM) vs TTM 1 Yr. Ago 4.30 6.61 8.02
Sales - 5 Yr. Growth Rate 26.67 10.48 10.85
EPS (MRQ) vs Qtr. 1 Yr. Ago -11.47 45.67 47.68
EPS (TTM) vs TTM 1 Yr. Ago 4.57 -- --
EPS - 5 Yr. Growth Rate -- 9.91 10.47
Capital Spending - 5 Yr. Growth Rate 24.28 15.26 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.07 2.18
Current Ratio (MRQ) -- 2.87 2.98
LT Debt to Equity (MRQ) -- 8.87 11.35
Total Debt to Equity (MRQ) -- 12.87 16.02
Interest Coverage (TTM) 12.36 32.47 28.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 57.74 52.10 52.41
Gross Margin - 5 Yr. Avg. 49.73 49.66 50.39
EBITD Margin (TTM) 22.58 -- --
EBITD - 5 Yr. Avg 22.31 17.26 12.43
Operating Margin (TTM) 19.56 13.53 5.77
Operating Margin - 5 Yr. Avg. 19.17 13.69 8.02
Pre-Tax Margin (TTM) 19.89 11.90 4.80
Pre-Tax Margin - 5 Yr. Avg. 17.92 14.11 8.31
Net Profit Margin (TTM) 14.90 8.81 1.53
Net Profit Margin - 5 Yr. Avg. 13.35 10.60 4.72
Effective Tax Rate (TTM) 25.12 22.12 22.13
Effective Tax Rate - 5 Yr. Avg. 25.54 22.26 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) 10,729,520 928,329,132 820,308,580
Net Income/Employee (TTM) 1,598,198 105,132,015 92,854,694
Receivable Turnover (TTM) -- 5.84 5.82
Inventory Turnover (TTM) -- 2.57 3.41
Asset Turnover (TTM) -- 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 10.98 10.60
Return on Assets - 5 Yr. Avg. 12.97 12.41 11.78
Return on Investment (TTM) -- 14.23 13.82
Return on Investment - 5 Yr. Avg. 24.24 16.18 15.32
Return on Equity (TTM) -- 15.46 15.24
Return on Equity - 5 Yr. Avg. 29.61 17.07 16.41
  1 Year 3 Year 5 Year
Sales % 8.13 23.05 26.67
EPS (TTM) % 13.48 25.05 --
Dividend % 0.00 18.56 37.97
Note: Units in Millions of US Dollars

Performance for Aurobindo Pharma Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 0.94 0.54 99 31
13 Week 7.02 5.50 99 42
26 Week 13.37 5.86 99 45
52 Week -12.94 -23.08 99 9
YTD 11.46 -6.72 99 37
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 25.58%
# of Holders: 183
Total Shares Held: 149,896,451
3 Mo. Net Change: 803,302
# New Positions: 10
# Closed Positions: 8
# Increased Positions: 61
# Reduced Positions: 46
# Net Buyers: 15
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.